Skip to content

US · SSII · MEDICAL - DEVICES

SS Innovations International, Inc. (SSII) intrinsic value and stock valuation

$1.27as of 2026-11-21 · Mkt cap 770.51M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

SS Innovations International, Inc. DCF and intrinsic value

InvestorsCraft values SSII with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from SSII’s statements →

SS Innovations International, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Healthcare · Medical - Devices Fort Lauderdale, FL 33316 ssinnovations.com

How the business is doing

Fiscal 2015–2025, USD

Revenue
$42.5M
20152025
Net income
-$-12.13M
20152025
Free cash flow
-$-22.2M
20162025
Total equity
$38.2M
20162025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2015–2025, USD
20252024202320222021
Revenue$42.5M$20.7M$5.88M$1.46M$0.00
Operating income-$-8.19M-$-18.98M-$-20.67M-$-5.68M-$-1.41M
Net income-$-12.13M-$-19.15M-$-20.94M-$-5.6M-$-1.48M
EPSd-$-61.05K-$-105.28K-$-163.02K-$-1.41M-$-519.3K
Operating cash flow-$-18.54M-$-9.5M-$-15.36M-$-5.99M-$-360K
Capital expenditure-$-3.66M-$-660K-$-450K$4.56M$0.00
Free cash flow-$-22.2M-$-10.16M-$-15.81M-$-1.44M-$-360K
Total assets$74.2M$42.4M$25.5M$6.98M$430K
Total debt$14.4M$18.2M$8.22M$8.27M$140K
Net debt$11.2M$17.7M$1.19M$8.05M-$-260K
Total equity$38.2M$13.5M$14.3M-$-2.68M$140K
Cash and short-term investments$3.21M$470K$7.03M$220K$410K
Income statement
20252024202320222021
Revenue$42.5M$20.7M$5.88M$1.46M$0.00
Cost of revenue$22.9M$12.2M$5.17M$970K$20K
Gross profit$19.5M$8.45M$710K$490K-$-20K
Research and development expenses$3.69M$2.49M$580K$80K$0.00
Selling, general and administrative expenses$23M$24.5M$20.8M$6.09M$1.39M
Other expenses$1.08M$440K$0.00$0.00$0.00
Operating expenses$27.7M$27.4M$21.4M$6.17M$1.39M
Cost and expenses$50.7M$39.6M$26.6M$7.14M$1.41M
Interest income$1.14M$800K$130K$240K$0.00
Interest expense$1.11M$970K$520K$160K$0.00
Depreciation and amortization$1.08M$440K$160K$130K$20K
Ebitda-$-5.98M-$-17.74M-$-20.26M-$-5.31M-$-1.47M
Operating income-$-8.19M-$-18.98M-$-20.67M-$-5.68M-$-1.41M
Total other income/expenses, net$30K-$-180K-$-270K$80K-$-80K
Income before tax-$-8.16M-$-19.15M-$-20.94M-$-5.6M-$-1.48M
Income tax expense$3.97M$0.00$0.00$0.00$0.00
Net income-$-12.13M-$-19.15M-$-20.94M-$-5.6M-$-1.48M
Weighted average shares outstanding$190M$170.8M$128.5M$3.98M$2.85M
Weighted average diluted shares outstanding$198.7M$181.9M$128.5M$3.98M$2.85M
Balance sheet
20252024202320222021
Cash and short-term investments$3.21M$470K$7.03M$220K$410K
Net receivables$12.4M$7.16M$1.65M$2.49M$0.00
Inventory$17.1M$10.2M$6.33M$900K$0.00
Total current assets$48.8M$27.4M$18.4M$4.1M$410K
Property, plant and equipment, net$11.9M$8.01M$2.99M$1.92M$20K
Goodwill and intangible assets$0.00$0.00$40K$40K$0.00
Long-term investments$9.03M$3.62M$2.64M$0.00$0.00
Total non-current assets$25.4M$15M$7.1M$2.89M$20K
Total assets$74.2M$42.4M$25.5M$6.98M$430K
Accounts payable$5.13M$2.89M$900K$170K$120K
Short-term debt$12M$15.9M$6.31M$6.43M$140K
Deferred revenue$3.27M$1.28M$0.00$0.00$0.00
Total current liabilities$26.2M$21.3M$9.27M$7.77M$290K
Long-term debt$2.34M$2.35M$1.91M$1.84M$0.00
Deferred revenue, non-current$7.14M$5.17M$0.00$40K$0.00
Total non-current liabilities$9.77M$7.6M$1.91M$1.89M$0.00
Capital lease obligations$2.34M$2.76M$2.2M$1.55M$0.00
Total liabilities$36M$28.9M$11.2M$9.66M$290K
Common stock$20K$20K$70K$10K$460K
Retained earnings-$-55.79M-$-43.66M-$-35.33M-$-3.63M-$-8.48M
Accumulated other comprehensive income (loss)-$-1.12M$150K$700K$950K$0.00
Total equity$38.2M$13.5M$14.3M-$-2.68M$140K
Total investments$9.03M$3.62M$2.64M$0.00$0.00
Total debt$14.4M$18.2M$8.22M$8.27M$140K
Net debt$11.2M$17.7M$1.19M$8.05M-$-260K
Cash flow statement
20252024202320222021
Net income-$-12.13M-$-19.15M-$-20.88M-$-3.21M-$-1.48M
Depreciation and amortization$1.08M$440K$150K$100K$20K
Stock-based compensation$8.13M$14.3M$9.72M$0.00$770K
Change in working capital-$-15.79M-$-6.08M-$-9.66M-$-3.16M-$-850K
Accounts receivable-$-13.04M-$-4.89M-$-3.07M-$-1.04M$0.00
Inventory-$-8.07M-$-7.69M-$-6.11M-$-780K$0.00
Accounts payable$2.88M$1.41M$740K$130K$0.00
Net cash provided by operating activities-$-18.54M-$-9.5M-$-15.36M-$-5.99M-$-360K
Investments in property, plant and equipment-$-3.66M-$-660K-$-450K$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$240K$40K
Net cash used for investing activities-$-3.66M-$-660K-$-450K$240K$40K
Common stock issued$0.00$0.00$410K$0.00$580K
Common stock repurchased$0.00$0.00$0.00$0.00-$-30K
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$26.2M$9.43M$22.8M$5.9M$570K
Net change in cash$2.98M-$-460K$6.81M-$-130K$250K
Cash at end of period$9.6M$6.62M$7.09M$270K$410K
Operating cash flow-$-18.54M-$-9.5M-$-15.36M-$-5.99M-$-360K
Capital expenditure-$-3.66M-$-660K-$-450K$4.56M$0.00
Free cash flow-$-22.2M-$-10.16M-$-15.81M-$-1.44M-$-360K
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About SS Innovations International, Inc.

        SS Innovations International, Inc., situated in Fort Lauderdale, Florida, focuses on the development of sophisticated robotic systems for surgical use. Their offerings encompass the SSI Mantra, a specialized surgical robot, and SSI Mudra, a suite of surgical instruments designed to facilitate various operations, including robotic cardiac surgery. The company also provides SSI Maya, a dedicated platform for robotic surgical interventions, along with OMNI 3D HD, which delivers a real-time, high-definition 3D perspective of the surgical field within the operating room.

        CEO
        Sudhir Prem Srivastava
        Employees
        483
        Beta
        0.67

        Explore

        Frequently asked questions

        What is the intrinsic value of SS Innovations International, Inc. (SSII)?

        InvestorsCraft does not currently publish an intrinsic value for SSII. How the IC value is calculated.

        Is SSII undervalued?

        InvestorsCraft does not publish an undervaluation signal for SSII at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.